INTRODUCTION {#SEC1}
============

G-quadruplexes are dynamic structures folded in G-rich single-stranded DNA regions. These structures have been recognized as a potential nucleic acid based mechanism for regulating multiple cellular processes such as replication, transcription and genomic maintenance. The main unit of a quadruplex consists of G-quartets formed by four guanine residues arranged in a planar structure. The stacking of three or more planar G-quartets establishes the G-quadruplex, which is stabilized mainly by potassium cations. One of the widely used consensus putative G-quadruplex sequence (PQS) is G~≥3~ N~1--7~ G~≥3~ N~1--7~ G~≥3~ N~1--7~ G~≥3~, wherein G-tracts are connected by loops of varying length and nucleotide (N) composition ([@B1]). The relative orientation of G-tracts defines parallel or antiparallel G-quadruplex topologies ([@B2],[@B3]). G-quadruplexes were initially found in telomeric DNA sequences; however, the discovery of the enriched presence of PQSs in gene promoters from bacteria to humans suggested a role of these structural motifs in transcriptional regulation, as well as a natural selection along evolution ([@B4]--[@B6]). G-quadruplexes are stable under physiological conditions *in vitro* ([@B7]) and their existence in the human genome has been recently demonstrated *in cellulo* ([@B8]). In addition, a number of studies using small G-quadruplex-targeting ligands support a transcriptional role of G-quadruplex *in cellulo* ([@B9]) and *in vivo* in early zebrafish (*Danio rerio*) embryos ([@B10]). However, nonspecific or pleiotropic effects of these ligands could not be ruled out, as animal genomes possess numerous genes containing at least one G-quadruplex near the transcription start site (TSS) ([@B11]). Reinforcing the notion of a fundamental role of G-quadruplexes in the biology of living organisms, numerous reports have indirectly demonstrated the involvement of G-quadruplexes in human disease ([@B12]). While in recent years the knowledge about the biological role of the G-quadruplex has made significant progress, the challenge still lies in proving the direct role of these structures on a specific biological process in a complex living organism.

During embryonic development, gene expression is orchestrated by specific and highly evolutionarily conserved mechanisms that take place accurately, both at spatial and temporal levels ([@B13]). An intricate array of *cis*-regulatory sequences controlling individual genes leads to a fine-tuning of gene expression in different developmental processes, which in turn may set up specific phenotypes both in health and disease. The last decades have provided compelling evidence that not only protein-mediated transcriptional control but also chromatin state play essential roles in orchestrating all stages of embryonic development ([@B14],[@B15]). In this context, we wondered whether G-quadruplexes contribute to the transcriptional control of genes required for the proper vertebrate embryonic development.

In this work we present evidences gathered by using combined computational and experimental analyses showing that evolutionarily conserved G-quadruplexes found in the promoters of the developmentally related genes *nog3, col2a1* and *fdz5* regulate *in vivo* their transcriptional activity during zebrafish embryonic development. To our knowledge, this is the first work reporting the G-quadruplexes as *cis*-acting elements contributing to the complex regulatory network that orchestrates the success of vertebrate embryonic development.

MATERIALS AND METHODS {#SEC2}
=====================

Bioinformatics {#SEC2-1}
--------------

Gene promoter sequences were searched and retrieved by using Ensembl Biomart tool (<http://www.ensembl.org/biomart/martview>) ([@B16]) and genome versions Zv9 (*Danio rerio*); GRCh37.p10 (*Homo sapiens*), and GRCm38.p1 (*Mus musculus*). Proximal promoter regions (PPRs) were defined as the region spanning 1000 bp upstream from reported TSS. Unique orthologous gene lists were generated using *Mus musculus* gene information as reference nomenclature. PQSs were searched using Quadparser algorithm ([@B1]). Parameters were set to search for quadruplexes formed by the stacking of at least three guanine tetrads with loop sequence lengths spanning from 1 to 7 nucleotides. Gene lists intersection was made using BioVenn ([@B17]). Gene Ontology (GO) data and GO term enrichment was analyzed with Biological Networks Gene Ontology (BiNGO) plugin using Cytoscape v2.8 (<http://www.cytoscape.org/>) ([@B18]). GO terms statistical significance was analyzed using a hypergeometric test and a Benjamini & Hochberg false discovery rate correction (FDR).

Oligonucleotides and compounds {#SEC2-2}
------------------------------

Synthetic desalted single-stranded oligodeoxyribonucleotides were purchased from Invitrogen^TM^, dissolved in bidistilled water and stored at −20°C. Concentrations of all oligonucleotides were determined by spectrometry using extinction coefficients provided by the manufacturer. Oligonucleotides used as primers for polymerase chain reactions (PCRs) were designed using Primer-BLAST (<http://www.ncbi.nlm.nih.gov/tools/primer-blast/>) and their specificity checked using MFE primer 2.0 (<http://biocompute.bmi.ac.cn/CZlab/MFEprimer-2.0/>). Sequences are listed in Supplementary Table S1. Mutations in G-quadruplex forming oligonucleotides were rationalized based on G-tracts disruption and were tested *in silico* using the QGRS Mapper software ([@B19]) and Quadparser algorithm ([@B1]).

Thioflavin T (ThT or 3,6-Dimethyl-2-(4-dimethylaminophenyl) benzothiazolium cation) was obtained from Sigma-Aldrich (Ref. T3516) and used without further purification. The concentration was calculated using the molar extinction coefficient in water at 412 nm of 36000 M^−1^cm^−1^ ([@B20]). The cationic porphyrins meso-Tetra (N-methyl-4-pyridyl) porphine tetrachloride (TMPyP4) and meso-Tetra (N-methyl-2-pyridyl) porphine tetrachloride (TMPyP2) were purchased from Frontier Scientific (Logan, Utah, USA) and used without further purification. The concentration of each porphyrin drug was calculated using the molar extinction coefficients in water at 424 nm of 226000 M^−1^cm^−1^ for TMPyP4, and at 414 nm of 182000 × M^−1^cm^−1^ for TMPyP2 ([@B21]).

ThT fluorescence assays {#SEC2-3}
-----------------------

ThT fluorescence assays were performed as described elsewhere ([@B20]) with slight modifications. Briefly, before analysis, oligonucleotides were heated at 95°C for 5 min at 2 μM concentration in 100 mM Tris-HCl, pH 7.5, 100 mM KCl and slowly cooled to room temperature over 2 h. Then, oligonucleotides and ThT were mixed at 1 and 0.5 μM final concentrations, respectively, in 50 mM Tris-HCl, pH 7.5 and 50mM KCl in a volume of 200 μl using 96-well microplates (Greiner). Fluorescence emission measurements were performed at room temperature using a microplate reader (Synergy 2 Multi-Mode Microplate Reader, BioTek) with excitation filter of 485 ± 20 nm and an emission filter of 528 ± 20 nm. Each oligonucleotide was tested by triplicate and fluorescence values were relativized to ThT fluorescence in the absence of oligonucleotides. Pu18 and Pu27 oligonucleotides representing G-quadruplex from human *c-MYC* promoter were used as positive controls, while mutated versions of Pu18 and Pu27 that disrupt G-quadruplex formation as negative controls ([@B22]).

Circular dichroism (CD) spectroscopy {#SEC2-4}
------------------------------------

Oligonucleotides (Supplementary Table S1) were heated at 95°C for 5 min at 2 μM concentration in 10 mM Tris-HCl, pH 7.5, with or without the addition of 100 mM KCl, and slowly cooled to room temperature over 2 h. CD spectra were recorded at room temperature over a wavelength range of 220--320 nm with a Jasco-810 spectropolarimeter (1 cm quartz cell, 100 nm/min scanning speed, 1 s response time, average of four scans). The spectral contribution of buffers, salts and drugs were appropriately subtracted by using the software supplied with the spectropolarimeter.

In cellulo luciferase reporter experiments {#SEC2-5}
------------------------------------------

*In cellulo* experiments were performed as described elsewhere ([@B23]). Briefly, duplex DNAs were generated by annealing oligonucleotides representing PQSs (or their mutated versions impeding G-quadruplex formation) with their complementary strands (Supplementary Table S1) and then cloned upstream the basal SV40 promoter by blunt-end ligation in SmaI digested pGL3-promoter vector plasmid (Promega). Several clones were sequenced and those that contained the PQSs or their mutated versions in the same strand (coding or template) as they are found in genomes were used for transfections. Mouse neuroblastoma cell line Neuro-2a (ATCC CCL-131) was cultured and transfected as previously described ([@B23]) with 0.5 μg of unmodified pGL3-promoter vector plasmid or reporter constructs. In addition, all dishes were co-transfected with 0.5 μg of pCMV-β-galactosidase (Promega) as a control for transfection efficiency. Luciferase activity was measured as described ([@B23]), normalized to β-galactosidase activity and expressed as a ratio of luciferase/β-galactosidase. Finally, values determined for wild-type and mutated PQSs constructs were relativized to those for pGL3-promoter vector plasmid. Experiments were repeated three times.

Animal handling and microinjection of zebrafish embryos {#SEC2-6}
-------------------------------------------------------

Animal handling during this study was carried out in strict accordance with relevant local, national and international guidelines. Protocols were approved by the Committee on the Ethics of Animal Experiments of the Universidad Nacional de Rosario (Expedient No. 6060/132; Resolution No. 298/2012). Adult zebrafish were maintained at 28°C on a 14 h light/10 h dark cycle. One-cell embryos were injected and embryos and larvae were staged according to development at 28°C as described elsewhere ([@B24]). For TMPyP4/2, 5 nl of each drug were injected in several dilutions in water ranging from 0.5 to 10 μM to determine the highest sub-toxic dose. For assays, 5 nl of TMPyP4/2 in a concentration of 1 μM were injected, and embryos were raised up to 48 h post-fertilization (hpf) stage to perform RT-qPCR. For oligonucleotides, 5 nl of CTRL oligonucleotide (Supplementary Table S1) were injected in several dilutions in KCl 0.1 M ranging from 0.001 to 100 ng/μl in order to determine the highest sub-toxic dose. For assays, 5 nl of 5 ng/μl of each oligonucleotide (Supplementary Table S1) in KCl 0.1 M were injected, and embryos were raised up to the corresponding stage to perform RT-qPCR. For *nog3* rescue experiments, zebrafish *nog3* capped-mRNA was synthesized using zebrafish *nog3* coding sequence cloned in pCS2+ plasmid ([@B25]) using SP6 mESSAGE mACHINE SP6 kit (Ambion) following the manufacturer\'s instructions. Five ng/μl of zebrafish *nog3* capped-mRNA were co-injected with the *nog3*-ASO or CTRL solutions.

RT-qPCR assays {#SEC2-7}
--------------

RNA extraction from zebrafish embryos at different stages was followed by reverse transcription and real-time quantitative PCR following previously reported procedures ([@B24]). Three biological and technical repeats were performed for each condition, resulting in similar trends. Data from one biological repeat are presented. The validity of the RT-qPCR data was assured by following the MIQE guidelines ([@B26]).

Cartilage staining {#SEC2-8}
------------------

Four-days post-fertilization (dpf) staged larvae were fixed for 24 h in 4% (w/v) paraformaldehyde (PFA) in phosphate-buffered saline 1X (PBS) containing 0.1% (v/v) Tween-20 and cartilages stained with Alcian Blue as previously described ([@B24]).

Whole-mount in situ hybridization (WISH) {#SEC2-9}
----------------------------------------

Embryos at different stages were fixed overnight in 4% (w/v) PFA in PBS at 4°C. After washing, embryos were stored in methanol at −20°C until use. The procedure for WISH was carried out as previously described ([@B24]). Digoxigenin-UTP-labeled riboprobes were synthesized by *in vitro* transcription using plasmid cloned template cDNAs for *col2a1a, krox20* (*erg2*), *myoD, fzd5* ([@B27]) and *tbx2b* ([@B28]) genes, or generated by PCR from genomic DNA for *nog3* gene ([@B29]).

Observation and measurement of embryonic morphologies {#SEC2-10}
-----------------------------------------------------

Live and fixed/stained embryos and larvae were observed with a MVX10 Stereo Microscope (Olympus) and recorded with a MVXTV1XC digital camera (Olympus). Lengths and angles for morphological features were measured from registered images using ImageJ software ([@B30]).

RESULTS {#SEC3}
=======

Searching for conserved PQSs in PPRs of vertebrate genes {#SEC3-1}
--------------------------------------------------------

PPRs (herein defined as 1000 bp upstream from the TSS) from *Homo sapiens, Mus musculus* and *Danio rerio* genomes were retrieved from ENSEMBL by using the BioMart tool. Orthologous genes were collated to generate a unique list according to the mouse nomenclature (Supplementary Table S2). PPRs from orthologous genes from each species were analyzed searching for at least one PQS by using the Quadparser algorithm (Figure [1A](#F1){ref-type="fig"},[B](#F1){ref-type="fig"}; Supplementary Tables S3--S5). No asymmetric pattern of PQS distribution between coding and template DNA-strands was observed. The absolute number and the percentage of PPRs containing PQSs increased from fish to mammals consistently with the increase of GC-percentage observed in the respective genomes (Figure [1B](#F1){ref-type="fig"}) ([@B31]). Then, the three lists of genes were intersected through the web application BioVenn (Figure [1A](#F1){ref-type="fig"},[C](#F1){ref-type="fig"}; Supplementary Table S2). Although the number of PPRs containing PQSs in the zebrafish genome is much lower than those found in mouse and human genomes, 50% of them are shared among the three species, 73% are shared with human and 60% with mouse. Similarly, PPRs containing PQSs shared between human and mouse are 64% of the human sequences and 72% of the mouse sequences (Figure [1C](#F1){ref-type="fig"}). Percentages higher than expected by chance suggest a positive selection of PQSs in PPRs throughout vertebrate evolution as well as a potential role for G-quadruplexes to act as transcriptional control elements. Identified genes encode proteins associated to a variety of biological processes (Supplementary Table S6) according to the BiNGO tool (Figure [1A](#F1){ref-type="fig"}). GO-Biological Process terms related to development were significantly enriched (Supplementary Table S6), in agreement with previous report ([@B6]). Among the 120 genes related to development, 22 were selected since they are involved in different developmental processes (Supplementary Table S6). The 13 genes with conserved PQS-strand location (coding or template) were selected for further studies (Figure [1A](#F1){ref-type="fig"} and Supplementary Table S6). When more than one PQS was identified in the same PPR, the one presenting similar relative position respect to the TSS in the three species was selected (Supplementary Table S6).

![Selection strategy of conserved PQSs *in silico*. (**A**) Schematic representation of conserved PQS selection strategy. (**B**) Chart representing the number of genes retrieved in each step of the bioinformatic search for the analyzed species. GC contents (%) were obtained from Kai et al. ([@B31]). (**C**) The three lists of genes containing PQSs in their PPRs obtained for the three species were intersected using BioVenn software.](gkw011fig1){#F1}

Testing the formation of G-quadruplex in selected PQSs in vitro {#SEC3-2}
---------------------------------------------------------------

Synthetic single-stranded oligodeoxyribonucleotide sequences representing the human and zebrafish PQSs of the 13 selected genes (Supplementary Table S1) were used to assess *in vitro* whether they fold as G-quadruplexes. First, we tested G-quadruplexes folding in an assay using ThT. This benzothiazole dye becomes fluorescent in the presence of the G-quadruplex structure but not in presence of duplex or single-stranded DNA ([@B20]). Those PQSs from human and zebrafish that increased the fluorescence of ThT by at least 25-times (Figure [2A](#F2){ref-type="fig"}) were selected for further CD spectroscopy analyses ([@B32]). CDs performed on PQSs folded in the presence of 100 mM K^+^ showed a sharp positive peak around 262 nm and a negative peak around 240 nm for most PQSs (Figure [2B](#F2){ref-type="fig"},[C](#F2){ref-type="fig"}; and Supplementary Figure S1), indicative of parallel topologies of G-quadruplexes. The oligonucleotide sequence representing the PQS from zebrafish *frizzled-5* (*fzd5*) displayed a CD spectrum exhibiting a maximum around 295 nm (Figure [2B](#F2){ref-type="fig"},[C](#F2){ref-type="fig"}; and Supplementary Figure S1), indicating an antiparallel topology. Results show that seven genes from human and zebrafish contain sequences capable of folding as G-quadruplex in their PPRs.

![*In vitro* analysis of G-quadruplex formation by ThT assays and circular dicroism. (**A**) Bar graph of fluorescence enhancement (F/F~0~) of ThT in the presence of the different oligonucleotides representing human and zebrafish selected PQSs. Each bar represents the mean of three technical repeats and error bars correspond to standard deviation (SD). (**B**) CD spectra of oligonucleotides representing human PQSs of the seven selected genes positive for ThT assay (*apba1, col2a1, fzd5, map3k1, nog3, nr2e1* and *shox2*) and two control genes negative for ThT assay (*jun* and *gnaq*). (**C**) CD spectrum of oligonucleotides representing zebrafish PQSs of the seven selected genes positive for ThT assay (*apba1, col2a1, fzd5, map3k1, nog3, nr2e1* and *shox2*) and two control genes negative for ThT assay (*jun* and *gnaq*).](gkw011fig2){#F2}

Selection of genes for studying the role of G-quadruplex in cellulo and in vivo {#SEC3-3}
-------------------------------------------------------------------------------

Among the seven potential key genes, we have selected *noggin 3* (*nog3), collagen type II alpha 1* (*col2a1*) and *fzd5* for further studies because: (i) their PQSs increased by at least 25-times the fluorescence of ThT; (ii) in the case of zebrafish, PQSs present in *col2a1* and *nog3* PPRs fold as parallel while the PQS in the *fzd5* PPR fold as antiparallel G-quadruplex (Figure [2B](#F2){ref-type="fig"}); (iii) PQSs in *col2a1* and *fzd5* PPRs locate to the coding DNA-strand whereas PQS in *nog3* PPR locates to the template DNA-strand (Supplementary Table S6); and (iv) changes in the abundance of their transcripts during embryonic development lead to well-defined and non-fully overlapping phenotypes ([@B25],[@B33]--[@B35]). Sequences, strand locations and relative positions of the human and zebrafish PQSs for the three selected genes are summarized in Figure [3A](#F3){ref-type="fig"}.

![*Col2a1, fzd5* and *nog3* PQSs and their role in transcriptional expression control *in cellulo*. (**A**) Chart presenting the sequences, strand locations and relative positions for the PQSs present in the PPRs of the three selected human and zebrafish genes. G-tracts are bold and underlined. Arrowheads point the G to A replacements in mutated PQSs. \*Relative positions are considering TSS as +1. (**B**) Luciferase assay performed in Neuro-2a cells transfected with pGL3-promoter vector plasmid (no PQS) or pGL3-promoter vector plasmid containing the wild type (wild-type PQS) or mutated (mutated PQS) sequence of human or zebrafish PQSs of the three selected genes upstream the basal promoter SV40. Each bar represents the luciferase activity normalized to β-galactosidase activity and relativized to that for the unmodified pGL3-promoter vector plasmid. Bars represent the mean of three independent experiments and error bars correspond to standard deviation (SD). \*\**P* \< 0.01, \*\*\**P* \< 0.001, t-Student test.](gkw011fig3){#F3}

Role of identified PQSs on transcriptional expression control in cellulo {#SEC3-4}
------------------------------------------------------------------------

The *in vitro* studies presented so far have established that the conserved PQSs located to the PPRs of *nog3, col2a1* and *fzd5* are capable of forming G-quadruplexes. However, the key question is whether they are critical for regulating the transcriptional activity. To address this, luciferase reporter plasmids were built by cloning the six sequences representing each PQS (three from human PPRs and three from zebrafish PPRs) upstream the basal SV40 promoter in the pGL3 promoter vector. Each PQS was cloned in the same DNA-strand (coding or template) as they are found in genomes. Additional constructs were done replacing guanines with adenines in G-tracts thus impeding G-quadruplex formation (Figure [3A](#F3){ref-type="fig"}, Supplementary Table S1 and Supplementary Figure S2). Plasmids were transiently transfected in Neuro-2a cells and the luciferase activity was measured as a transcriptional reporter. With the exception of human *fzd5*-PQS, luciferase expression controlled by PQSs was significantly higher than that detected for the basal SV40 promoter. This result confirms that the analyzed PQSs are able to regulate the activity of the unrelated SV40 promoter. Reinforcing this finding, luciferase expression controlled by mutated PQSs was significantly lower than that controlled by the wild-type ones, and reaching similar levels than the expression controlled by the SV40 promoter. The human *fzd5*-PQS caused a repression in the transcription of the reporter gene. Yet, the mutated sequence led to luciferase-transcript abundance even lower than that detected for the wild-type sequence (Figure [3B](#F3){ref-type="fig"}). Results indicate that PQSs present in the PPRs of human and zebrafish *nog3, col2a1* and *fzd5* genes are able to fold as G-quadruplexes and regulate *in cellulo* the SV40-dependent transcription.

Role of G-quadruplex in transcriptional expression control in vivo {#SEC3-5}
------------------------------------------------------------------

Data generated *in cellulo* confirmed that G-quadruplexes are able to regulate the activity of the SV40 promoter thus influencing the expression of a reporter gene. However, the real effect of these structures in a cellular and genomic natural context might be different. Thereby, the key question was if G-quadruplexes were really involved in transcriptional regulation *in vivo* during development. To answer this, we disrupted the G-quadruplex structures by microinjecting small G-quadruplex-targeting ligands in one-cell staged zebrafish embryos and then measuring the relative abundance of transcripts by RT-qPCR. We used the small cationic porphyrin TMPyP4 that has been reported to act as both a stabilizer and a destabilizer of G-quadruplexes depending upon the target ([@B36]--[@B39]). Although TMPyP4 can interact with both G-quadruplexes and duplex DNA, it has a higher selectivity for the G-quadruplex than for the duplex structure ([@B40]). We also used the cationic porphyrin TMPyP2, which is a positional isomer of TMPyP4 and has a lower affinity for G-quadruplexes ([@B41]). Compared to TMPyP2, the presence of TMPyP4 did not significantly modify the abundance of *col2a1* transcripts at 48-hpf; however, it led to a significant decrease in the abundance of *nog3* and *fzd5* transcripts measured. The relative abundance of *actin beta 2* (*actb2*) transcripts did not show significant changes, as expected because it is a housekeeping gene homogeneously expressed throughout embryonic development and that does not contain PQSs in its PPR (Figure [4A](#F4){ref-type="fig"}). The magnitude of CD signals revealed that TMPyP4 destabilized G-quadruplexes when comparing with TMPyP2 (Supplementary Figure S3), suggesting that the transcriptional effect of TMPyP4 was due to an *in vivo* destabilization of G-quadruplexes. Nevertheless, unspecific or pleiotropic effects of small ligands could not be ruled out because more than 6% of zebrafish genes contain at least one PQS motif near the TSS (Figure [1B](#F1){ref-type="fig"}). Thereby, a more specific experimental approach consisting of microinjecting ASOs complementary to the selected PQSs was performed. In previous report, ASOs had been used in zebrafish embryos for *in vivo* testing the role of the human *c-MYC* G-quadruplex in controlling the expression of luciferase ([@B42]). Worth noticing, these data were generated by microinjecting plasmid DNA containing the targeted G-quadruplex and might not reflect what is really happening on promoters of endogenous genes. In the present study, in addition to the ASOs complementary to the selected PQSs (Supplementary Figure S4A), ASOs complementary to either the template or the coding strands of the *actb2* PPR were designed to be used as specificity controls. An oligonucleotide that does not anneal to the zebrafish genome was used as unspecific control (CTRL, Supplementary Table S1). The effect of ASOs on the G-quadruplexes - duplex DNA equilibrium was tested *in vitro* by PAGE and ThT assays. Duplex DNA was the predominant form observed in PAGE when ASOs were present during or posterior to the G-quadruplexes folding (Supplementary Figure S4B). Data from ThT assays confirmed these observations (Supplementary Figure S4C). In agreement with Triplexator software predictions ([@B43]), duplex DNA containing the PQSs incubated in the presence of ASOs did not form triplex DNA structures (Supplementary Figure S4D). Thereby, results show that ASOs interfere the G-quadruplex folding by forming duplex- but not triplex-DNA structures with PQSs.

![Disruption of G-quadruplexes by G-quadruplex ligands and ASO injection affects transcriptional expression in zebrafish embryos. (**A**) Relative abundance of transcripts of *col2a1, fzd5, nog3* and the control *actb2* genes measured by RT-qPCR in 48-hpf embryos injected with the drugs TMPyP2 and TMPyP4. (**B**) Relative abundance of transcripts of *col2a1, fzd5, nog3* and the control *actb2* genes measured by RT-qPCR in 90% epiboly, 30-hpf and 48-hpf staged embryos, respectively, injected with the ASO complementary to the corresponding PQS. In the case of *actb2* gene, two ASOs were used, one complementary to the template (*actb2*(+)-ASO) and the other to the coding strand (*actb2*(-)-ASO). In all cases, three biological and technical repeats were performed for each condition, resulting in similar trends. Bars represent the mean of the three technical repeats for one representative biological repeat. Error bars correspond to standard deviation (SD) of the three technical repeats. \**P* \< 0,05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, t-Student test.](gkw011fig4){#F4}

Then, the toxicity of ASOs was defined *in vivo* by injecting different concentrations of CTRL in one-cell staged zebrafish embryos and assessing the survival of specimens until 48-hpf. The higher sub-toxic dose was defined as 25 pg-ASO/embryo (i.e. 5 nl of 5 ng/μl; Supplementary Figure S5). The relative abundance of *nog3, col2a1* and *fdz5* transcripts in ASO-injected embryos was measured by RT-qPCR at those developmental stages in which either a sharp increment of the transcription (Supplementary Figure S6) or well-defined knock-down phenotypes were detected ([@B25],[@B33]). Compared to CTRL injected embryos, the presence of specific ASOs led to a significant decrease in the relative abundance of *nog3, col2a1* and *fdz5* but not of *actb2* transcripts (Figure [4B](#F4){ref-type="fig"}), ruling out pleiotropic and unspecific effects due to the toxicity of oligonucleotides. In addition, the absence of transcriptional effect in the presence of *actb2*-ASOs indicated that changes in transcripts abundances were due to the G-quadruplexes disruption and not solely to the annealing of ASOs with PPRs. Overall, results indicate that G-quadruplexes interference reduces *in vivo* the transcription of the three genes under study.

G-quadruplex disruption mimics the effect of col2a1, fdz5 and nog3 knock-down during zebrafish embryonic development {#SEC3-6}
--------------------------------------------------------------------------------------------------------------------

Next, we wondered whether the impediment of G-quadruplex formation had any effect on the patterning of embryonic developmental structures. To answer this issue, we compared the phenotypes and the spatiotemporal expression patterns generated in the presence of ASOs with those ones reported when the expression of the three genes under study had been knocked-down by specific Morpholinos (MO).

Collagen II, coded by the *col2a1* gene, is the major fibril-forming collagen in cartilage. Complete absence of collagen II in mice is not compatible with life and mutations in the human\'s *COL2A1* gene lead to osteochondrodysplasias with diverse phenotypes, from prenatally lethal and short stature to relatively mild defects that may be apparent only in adulthood ([@B44]). In zebrafish, *col2a1-*MO-knocking-down leads to ventrally curved organisms ([@B34]) displaying aberrant notochord morphology ([@B35]). Compared to CTRL injected embryos, the presence of *col2a1*-ASO did not cause a noticeable effect on the percentage of dead and deformed embryos but led to a significant increase in the amount of 24-hpf staged embryos showing a ventral curvature phenotype (Figure [5A](#F5){ref-type="fig"}) and high number of 4-dpf staged larvae displaying significant shortening in the body length (Figure [5B](#F5){ref-type="fig"},[C](#F5){ref-type="fig"}). The presence of *col2a1*-ASO did not significantly affect the craniofacial cartilage development (Supplementary Figure S7A). WISH revealed that *col2a1*-ASO injection produced slightly lower abundance of *col2a1-*mRNA at 90% epiboly and a thinner and anteriorly shorter notochord at 10-somite staged embryos (Figure [5D](#F5){ref-type="fig"}), which may explain the body shortening detected among larvae. No differences in the expression pattern of other developmental marker genes were observed (Supplementary Figure S7B), ruling out unspecific effects of the *col2a1*-ASO injection.

![Effect of *col2a1* G-quadruplex disruption by *col2a1-*ASO injection in zebrafish embryos. (**A**) Numbers and percentages of embryos showing dead, deformed, normal or ventral curvature phenotypes are shown in a table and represented in a stacked bar graph for 24-hpf staged embryos injected with CTRL or *col2a1*-ASO. \*\*\**P* \< 0.001, chi-square test. (**B**) Representative picture of 4-dpf staged larvae injected with CTRL or *col2a1*-ASO and stained with Alcian Blue to determine the body length. Lateral views, anterior to the left. (**C**) Box-plot of the relative body length of 4-dpf staged larvae injected with CTRL or *col2a1*-ASO. \**P* \< 0.05, t-Student test. (**D**) WISH assessing the expression of *col2a1* mRNA in 90% epiboly (i and ii) and 10-somite (iii and iv) staged embryos injected with CTRL (i and iii) or *col2a1*-ASO (ii and iv). Arrowheads point regions of lower expression. In lateral views anterior is to the left, and in dorsal and fronto-dorsal views anterior is up. Numbers and percentages of embryos/larvae with the shown phenotype are indicated in each panel. n: notochord. Scale bars (200 μm) are represented in B, Di and Diii.](gkw011fig5){#F5}

*Fzd5* expression is highly restricted to eye, forebrain and gut in zebrafish developing embryos ([@B27]) and its knocking-down causes a reduction of the eye field ([@B33]). The microinjection of *fzd5*-ASO did not cause a noticeable effect on the percentage of dead and deformed embryos when comparing to controls but led to a significant increase in the number of embryos showing a reduced-eye phenotype (Figure [6A](#F6){ref-type="fig"}) and a statistically significant reduction in the eye diameter (Figure [6B](#F6){ref-type="fig"},[C](#F6){ref-type="fig"}). In addition, WISH revealed lower *fzd5* expression in the eye territory mainly from 10-somite staged embryos onward (Figure [6D](#F6){ref-type="fig"}). No difference in expression pattern of a typical developmental marker gene was detected (Supplementary Figure S8), ruling out unspecific effects of the *fzd5*-ASO injection.

![Effect of *fzd5* G-quadruplex disruption by *fzd5-*ASO injection in zebrafish embryos. (**A**) Numbers and percentages of embryos showing dead, deformed, normal or reduced-eye phenotypes are shown in a table and represented in a stacked bar graph for 30-hpf staged embryos injected with CTRL or *fzd5*-ASO. \*\*\**P* \< 0.001, chi-square test. (**B**) Representative picture of 30-hpf staged embryos injected with CTRL or *fzd5*-ASO used to determine eye diameter. Lateral views, anterior to the left. (**C**) Box-plot of the relative eye diameter of 30-hpf staged embryos injected with CTRL or *fzd5*-ASO. \*\*\**P* \< 0.001, t-Student test. (**D**) WISH assessing the expression of *fzd5* mRNA in 2-somite (i and ii), 10-somite (iii and iv), 15-somite (v and vi) and 30-hpf (vii and viii) staged embryos injected with CTRL (i, iii, v and vii) or *fzd5*-ASO (ii, iv, vi and viii). Arrowheads point regions of lower expression. In lateral views anterior is to the left, and in fronto-dorsal views anterior is up. Numbers and percentages of embryos/larvae with the shown phenotype are indicated in each panel. e: eye; vdc: ventral diencephalon. Scale bars (200 μm) are represented in B, Di, Diii, Dv and Dvii.](gkw011fig6){#F6}

*Nog3* seems to play an important role in chondrogenic progenitor survival during zebrafish pharyngeal development since its knock-down led to ventral pharyngeal cartilages severely reduced in size ([@B25]). The microinjection of *nog3*-ASO did not cause a noticeable effect on the percentage of dead and deformed embryos when comparing to controls, but led to a significant increase in the number of embryos showing a small-head phenotype (Figure [7A](#F7){ref-type="fig"}). Statistically significant changes in the angle formed by ceratohial cartilages and in the number of ceratobranchial cartilages were detected by Alcian Blue staining (Figure [7B](#F7){ref-type="fig"},[C](#F7){ref-type="fig"}). Defects were specifically caused by *nog3*-ASO since they were fully rescued by *nog3*-mRNA co-injection (Supplementary Figure S9). WISH assessing the expression of the marker of differentiated chondrocytes *col2a1* in *nog3*-ASO injected embryos showed shorter trabeculae cranii development and a compression of pharyngeal arches while no significant changes were observed in the otic vesicle expression territory (Supplementary Figure S10). Besides, WISH revealed lower expression of *nog3* in pharyngeal arches and pectoral fins and in a shortened trabeculae cranii (Figure [7D](#F7){ref-type="fig"}). No significant changes in the expression of *col2a1* in the otic vesicle territory along with rescue data point out the specificity of *nog3*-ASO. In agreement with the results described above, embryos injected with both *actb2*-ASOs did not produced evident developmental phenotypes (Supplementary Figure S11).

![Effect of *nog3* G-quadruplex disruption by *nog3-*ASO injection in zebrafish embryos. (**A**) Numbers and percentages of embryos showing dead, deformed, normal or small head phenotypes are shown in a table and represented in a stacked bar graph for 48-hpf staged embryos injected with CTRL or *nog3*-ASO. \*\*\**P* \< 0.001, chi-square test. (**B**) Representative picture of Alcian Blue staining of craniofacial cartilages in 4-dpf staged larvae injected with CTRL or *nog3*-ASO. Ventral views, anterior to the left. (**C**) Box-plots of the relative ceratohyal cartilages angle and ceratobranchial cartilages number of 4-dpf staged larvae injected with CTRL or *nog3*-ASO. \**P* \< 0.05, t-Student test. (**D**) WISH assessing the expression of *nog3* mRNA in 56-hpf staged larvae injected with CTRL (i) or *nog3*-ASO (ii). Arrowheads point regions of lower expression. In lateral and dorsal views anterior is to the left. Numbers and percentages of embryos/larvae with the shown phenotype are indicated in each panel. ca: ceratohyal cartilages angle; cb (3-7): ceratobranchial cartilages 3 to 7; ch: ceratohyal cartilage; pa: pharyngeal arches; pf: pectoral fin; tc: trabeculae cranii. Scale bars (200 μm) are represented in B and Di.](gkw011fig7){#F7}

Collectively, data presented here show that conserved G-quadruplexes present in the PPRs of developmentally related genes play transcriptional regulatory roles and are required to achieve the proper development of embryonic structures.

DISCUSSION {#SEC4}
==========

In this work we presented results supporting G-quadruplexes as additional members of the intricate array of *cis*-regulatory sequences responsible for the transcriptional control during embryonic development. Enrichment of genes related to developmental processes among those containing conserved PQSs in their PPRs suggests a functional selection of G-quadruplexes likely participating in accurate transcriptional regulation throughout development. Although this analysis was performed in zebrafish, the vast majority of candidate sequences are conserved between fish and mammals. Therefore, it is likely that the transcriptional control by G-quadruplexes characterized in fish also exists in other vertebrate systems. As mammalian PPRs contain higher number of PQSs due to a genome GC-enrichment along evolution, it is tempting to speculate that the contribution of G-quadruplexes to the transcription of mammalian developmentally related genes is even more relevant than in zebrafish. In this work we have only assessed the 1000 bp upstream from TSS region of a set of developmentally related genes. Because G-quadruplexes may also regulate transcription at long distances from the TSS ([@B45]--[@B47]), the contribution of this non-canonical form of DNA to developmental transcriptional control may be even higher than that shown in this work. Although the zebrafish genome possesses a relatively scant number of PQSs within PPRs, most of them are conserved in mouse and human orthologous genes turning zebrafish into a good model for studying the role of G-quadruplexes in different developmental pathways, as well as other cellular processes.

Several studies performed *in silico* or *in cellulo* using reporter constructs suggest that G-quadruplexes act as transcriptional repressors by impeding transcription factor binding to duplex-DNA or stalling the progression of RNA polymerase, mostly when they are located downstream the TSS in the template strand ([@B3],[@B12],[@B48],[@B49]). Conversely, it was also shown that G-quadruplexes may enhance the transcription of particular genes by favoring the binding of specific transcription factors ([@B3],[@B42],[@B49],[@B50]) or by holding the DNA molecule open thus facilitating the re-initiation of transcription ([@B3],[@B49],[@B51]). With the exception of human *fdz5*-PQS, the experimental evidences gathered in this work indicate that G-quadruplexes located upstream the TSS of *col2a1, fzd5* and *nog3* enhance the transcription *in cellulo*. This enhancer effect would be due to the recruitment of specific activators on folded G-quadruplexes, the removal of a repressive process, and/or the fact that G-quadruplex holds the DNA molecule open thus facilitating the re-initiation of transcription. Regarding the human *fzd5*-PQS, we speculate that the inhibitory effect of the G-quadruplex on luciferase transcription might be due to the recruitment/binding of transcription suppressors or to an impediment in the correct transcriptional machinery assembly. *In cellulo* experiments also demonstrated that all of mutated sequences impairing G-quadruplex formation diminished the expression of luciferase. In the particular case of human *fdz5*-PQS, mutations might generate novel *cis*-repressor elements in the duplex-DNA that in turn recruit suppressors causing an even greater decrease in transcription. Collectively, the transcriptional effect was observed regardless of whether the tested sequences represented PQSs found in either human or zebrafish genomes, were located to the coding or template strand, or adopted parallel or antiparallel G-quadruplex topologies. Even more, as human and zebrafish PQSs are not conserved in primary sequence and luciferase was measured in Neuro2a cells (i.e. in a mouse cellular context), results strongly suggest that the transcriptional diminishing was actually due to deficiencies in G-quadruplexes folding and not to environmental or pleiotropic effects.

The ASO strategy, which had been successfully employed for assessing the transcriptional and translational role of G-quadruplex *in vivo* ([@B42],[@B52]), led to reduced transcription of the three analyzed genes along with phenotypes similar to those ones reported when the knocking-down had been performed by other experimental strategies. The sole presence of an ASO complementary to the PQS within the PPR of a particular gene generated phenotypes greatly related with its developmental function. This fact minimizes the chances that the obtained results were due to nonspecific or pleiotropic effects. Our results suggest that G-quadruplexes favor the transcription of zebrafish *nog3, col2a1* and *fzd5* likely by recruiting activators or impeding the binding of suppressors to the duplex-DNA, as well as by facilitating transcription re-initiation. Altogether, data support a role of G-quadruplexes in the transcriptional regulation of developmentally related genes and highlight ASO-strategy as a tool to get insight into the role of G-quadruplex during the embryonic development of complex living organisms.

Adjustments in the fine-tuning of gene expression controlling developmental processes may lead to phenotypic variations among healthy individuals, as well as stronger alterations leading to disease. A recent work has reported the existence of G-quadruplex polymorphisms affecting G-tracts or even loop-regions, which may result in significant changes in gene expression among individuals ([@B53]). In this context, it is tempting to speculate that G-quadruplex polymorphisms might contribute to the fine-tuning of the transcriptional regulation of critical developmental genes, with potential biological or even pathological consequences. If so, our knowledge and ability to manipulate the folding of the G-quadruplexes could become a powerful tool for preventing and treating diseases derived from aberrant embryonic developmental processes.

To our knowledge, this is the first work showing *in vivo* the direct role of evolutionarily conserved G-quadruplexes in one of the most strictly regulated biological process of vertebrates; i.e. the embryonic development.
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